150
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Emergence of ST1193 Clone in Maternal and Neonatal ESBL-Producing E. coli Isolates

, , , , , & show all
Pages 6681-6689 | Received 24 Apr 2023, Accepted 14 Sep 2023, Published online: 13 Oct 2023

References

  • Madec JY, Haenni M, Nordmann P, Poirel L. Extended-spectrum beta-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? Clin Microbiol Infect. 2017;23:826–833. doi:10.1016/j.cmi.2017.01.013
  • Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum β-lactamase-producing Enterobacteriaceae in children old foe, emerging threat. Clin Infect Dis. 2015;60:1389–1397. doi:10.1093/cid/civ020
  • Neemann K, Olateju EK, Izevbigie N, et al. Neonatal outcomes associated with maternal recto-vaginal colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in Nigeria: a prospective, cross-sectional study. Clin Microbiol Infect. 2020;26:463–469. doi:10.1016/j.cmi.2019.07.013
  • Birgy A, Mariani-Kurkdjian P, Bidet P, et al. Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. J Clin Microbiol. 2013;51:1727–1732. doi:10.1128/JCM.03255-12
  • Day MJ, Hopkins KL, Wareham DW, et al. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. Lancet Infect Dis. 2019;19:1325–1335. doi:10.1016/s1473-3099(19)30273-7
  • Chong Y, Shimoda S, Shimono N. Current epidemiology, genetic evolution and clinical impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol. 2018;61:185–188. doi:10.1016/j.meegid.2018.04.005
  • Danino D, Melamed R, Sterer B, et al. Mother-to-child transmission of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Hosp Infect. 2018;100:40–46. doi:10.1016/j.jhin.2017.12.024
  • Bulabula ANH, Dramowski A, Mehtar S. Maternal colonization or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in Africa: a systematic review and meta-analysis. Int J Infect Dis. 2017;64:58–66. doi:10.1016/j.ijid.2017.08.015
  • Jalilian N, Kooshkiforooshani M, Ahmadi S, Nankali A. Colonisation with extended-spectrum beta-lactamase-producing Enterobacteriaceae in pregnant/post-partum women: systematic review and meta-analysis. J Glob Antimicrob Resist. 2019;19:338–347. doi:10.1016/j.jgar.2019.06.010
  • Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63:310–318. doi:10.1093/cid/ciw283
  • Titelman E, Hasan CM, Iversen A, et al. Faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect. 2014;20:O508–515. doi:10.1111/1469-0691.12559
  • Overdevest I, Haverkate M, Veenemans J, et al. Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014. Euro Surveill. 2016;21. doi:10.2807/1560-7917.ES.2016.21.42.30376
  • van den Bunt G, Liakopoulos A, Mevius DJ, et al. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage. J Antimicrob Chemother. 2017;72:589–595. doi:10.1093/jac/dkw443
  • Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–327. doi:10.1016/s1473-3099(17)30753-3
  • Miao Z, Li S, Wang L, Song W, Zhou Y. Antimicrobial resistance and molecular epidemiology of esbl-producing Escherichia coli isolated from outpatients in town hospitals of Shandong Province, China. Front Microbiol. 2017;8:63. doi:10.3389/fmicb.2017.00063
  • Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13:19044.
  • Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54:969–976. doi:10.1128/AAC.01009-09
  • Ben-Ami R, Rodríguez‐Baño J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49:682–690. doi:10.1086/604713
  • Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66:1–14. doi:10.1093/jac/dkq415
  • Tchesnokova VL, Rechkina E, Larson L, et al. Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193. Clin Infect Dis. 2019;68:334–337. doi:10.1093/cid/ciy525
  • Platell JL, Trott DJ, Johnson JR, et al. Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother. 2012;56:3898–3904. doi:10.1128/AAC.06120-11
  • Sands K, Carvalho MJ, Portal E, et al. Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries. Nat Microbiol. 2021;6:512–523. doi:10.1038/s41564-021-00870-7
  • Solomon S, Akeju O, Odumade OA, et al. Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. PLoS One. 2021;16:e0255410. doi:10.1371/journal.pone.0255410
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. In: CLSI Supplement M100. 30th ed. Wayne, PA: CLSI; 2020.
  • European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. Version 7.0. 2017. Accessed 19 September, 2023.
  • Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–477. doi:10.1089/cmb.2012.0021
  • Treangen TJ, Ondov BD, Koren S, Phillippy AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014;15:524. doi:10.1186/s13059-014-0524-x
  • Jones RN, Castanheira M, Hu B, et al. Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers. Diagn Microbiol Infect Dis. 2011;77:258–266. doi:10.1016/j.diagmicrobio.2013.07.003
  • Quan J, Zhao D, Liu L, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother. 2017;72:273–280. doi:10.1093/jac/dkw372
  • Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543–574. doi:10.1128/CMR.00125-13
  • Johnson TJ, Elnekave E, Miller EA, et al. Phylogenomic analysis of extraintestinal pathogenic Escherichia coli sequence type 1193, an emerging multidrug-resistant clonal group. Antimicrob Agents Chemother. 2019;63. doi:10.1128/AAC.01913-18
  • Ding Y, Zhang J, Yao K, Gao W, Wang Y. Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China. Eur J Clin Microbiol Infect Dis. 2021;40:833–840. doi:10.1007/s10096-020-04079-0
  • Xia S, Fan X, Huang Z, et al. Dominance of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One. 2014;9:e100707. doi:10.1371/journal.pone.0100707
  • Overdevest I, Willemsen I, Rijnsburger M, et al. Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis. 2011;17:1216–1222. doi:10.3201/eid1707.110209
  • Katip W, Yoodee J, Uitrakul S, Oberdorfer P. Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae. Sci Rep. 2021;11:18. doi:10.1038/s41598-020-78098-4
  • Katip W, Rayanakorn A, Oberdorfer P, Taruangsri P, Nampuan T. Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: a propensity score matching study. J Infect Public Health. 2023;16:1249–1255. doi:10.1016/j.jiph.2023.05.024
  • Gu S, Lai J, Kang W, et al. Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals A multicentre study across China. J Infect. 2022;85:499–506. doi:10.1016/j.jinf.2022.09.014
  • Anisimov R, Brem D, Heesemann J, Rakin A. Transcriptional regulation of high pathogenicity island iron uptake genes by YbtA. Int J Med Microbiol. 2005;295:19–28. doi:10.1016/j.ijmm.2004.11.007